Lupus

Online Consultation System Benefits Rheumatic Disease Management

Online Consultation System Benefits Rheumatic Disease Management

The SSDM series of applications is cost-effective for patients of rheumatologists.

Impact of Remission, Low Disease Activity on Outcomes in Lupus

Impact of Remission, Low Disease Activity on Outcomes in Lupus

By

While a treat to target strategy has been proposed for managing SLE, the impact of possible disease outcomes has not been fully evaluated.

Patients With SLE at Higher Risk of Developing Metabolic Syndrome

Patients With SLE at Higher Risk of Developing Metabolic Syndrome

More than 25% of SLE patients also have metabolic syndrome.

Complement System a Contributor to Lupus Clinical Manifestations

Complement System a Contributor to Lupus Clinical Manifestations

By

Mannose-binding lectin of the complement system may contribute to the development of clinical manifestations in SLE.

Advancing Understanding of Shrinking Lung Syndrome in SLE

Advancing Understanding of Shrinking Lung Syndrome in SLE

By

The diagnosis and management of shrinking lung syndrome, a rare complication of systemic lupus erythematosus, is discussed in a comprehensive review.

Systemic Lupus Erythematosus Activity in Pregnant Women Increases After Childbirth

Systemic Lupus Erythematosus Activity in Pregnant Women Increases After Childbirth

By

SLE was low to absent in pregnant women during conception and pregnancy, but increased after delivery.

Potential Cause of Lupus Could Lead to Novel Treatment Options

Potential Cause of Lupus Could Lead to Novel Treatment Options

A cause for the lupus disease may have been identified as a protein by a researcher at the Feinstein Institute for Medical Research.

Pediatric SLE Pulmonary Function Measures: FENO as Potential Biomarker

Pediatric SLE Pulmonary Function Measures: FENO as Potential Biomarker

By

FENO monitoring may provide a biomarker of disease activity and signify the emergence of pulmonary involvement in kids with SLE.

Diffuse Alveolar Hemorrhage in SLE Associated With Serious Disease Flare

Diffuse Alveolar Hemorrhage in SLE Associated With Serious Disease Flare

By

This condition is associated with serious disease flare complicated by sepsis and a high mortality rate.

Biomarkers of Pulmonary Arterial Hypertension Risk in SLE

Biomarkers of Pulmonary Arterial Hypertension Risk in SLE

By

Meta-analysis supports anti-RNP and anti-Sm antibodies as serological biomarkers of PAH risk in patients with systemic lupus erythematosus.

Patients With Systemic Lupus Erythematosus and Cognitive Dysfunction Prevalence

Patients With Systemic Lupus Erythematosus and Cognitive Dysfunction Prevalence

By

MOCA is more effective than the Mini-Mental State Examination at detecting cognitive dysfunction.

Patients With Lupus Have Poor Quality of Sleep, Quality of Life

Patients With Lupus Have Poor Quality of Sleep, Quality of Life

By

The majority of patients with systemic lupus erythematosus have poor quality of sleep.

Steroid Dosage as Risk Factor for Osteonecrosis in Patients With SLE

Steroid Dosage as Risk Factor for Osteonecrosis in Patients With SLE

By

Cumulative steroid dosage is a risk factor for the development of osteonecrosis.

Lymphoma in Patients With Systemic Lupus Erythematosus: Expert Insights

Lymphoma in Patients With Systemic Lupus Erythematosus: Expert Insights

By

In this expert interview, Sasha Bernatsky, MD, PhD, and Michelle Petri, MD, MPH, discuss the risk of non-Hodgkin lymphoma in SLE.

Lupus Severity, Treatment Affected By Socioeconomic Disparities

Lupus Severity, Treatment Affected By Socioeconomic Disparities

Socioeconomic and racial disparities are linked in the severity and treatment of lupus.

Lupus Low-disease Activity State Can Predict Flare-up Risk

Lupus Low-disease Activity State Can Predict Flare-up Risk

By

Asia-Pacific Lupus Collaborative's low-disease activity score can predict risk of flare-ups, according to research from a group at Hong Kong University.

Reduced Lupus Risk Linked to Moderate Alcohol Consumption in Women

Reduced Lupus Risk Linked to Moderate Alcohol Consumption in Women

By

The study evaluated 2 groups of women from the Nurses' Health Study (NHS) and NHSII cohorts, examining alcohol consumption and the onset of systemic lupus erythematosus.

The Handoff: Your Week in Rheumatology News - 3/24/17

The Handoff: Your Week in Rheumatology News - 3/24/17

By

New guidelines for rheumatoid arthritis treatment with DMARDs and money being steered into lupus research highlight this week's The Handoff.

Reduced Psychosocial Reserve Linked to Increased SLE Disease Burden

Reduced Psychosocial Reserve Linked to Increased SLE Disease Burden

By

Patients with systemic lupus erythematosus and low self-esteem reported higher levels of anxiety and depression.

Elevated Disease Markers Identified in Relatives of Patients With Lupus

Elevated Disease Markers Identified in Relatives of Patients With Lupus

By

Changes in levels of soluble mediators may predict SLE transition in unaffected relatives of patients.

Lupus Family Planning Recommendations Issued by EULAR

Lupus Family Planning Recommendations Issued by EULAR

By

A European League Against Rheumatism writing committee has issued recommendations for family planning for women with systemic lupus erythematosus and antiphospholipid syndrome based on a systemic review.

Lupus: Using Diet and Nutrition to Improve Symptoms and Outcomes

Lupus: Using Diet and Nutrition to Improve Symptoms and Outcomes

By

Consuming adequate amounts of the right nutrients, and limiting others, can help relieve symptoms and improve outcomes in patients with systemic lupus erythematosus.

Lupus Among Autoimmune Diseases Tied to Subsequent Dementia Risk

Lupus Among Autoimmune Diseases Tied to Subsequent Dementia Risk

By

Study reviewed information from 1.8 million individuals in England admitted to a hospital with an autoimmune disease.

The Handoff: Your Week in Rheumatology News - 2/17/17

The Handoff: Your Week in Rheumatology News - 2/17/17

By

Clinical management recommendations for juvenile dermatomyositis, updated guidelines for low back pain treatment, and more of this week's news.

Lupus Research Grants Available for Post-Graduate Study

Lupus Research Grants Available for Post-Graduate Study

By

The Lupus Foundation of America is now accepting applications for 8 grants, with dedicated awards to minority applicants, pediatric research, and research that has an impact on rural areas.

<i>In Vitro</i> Fertilization is Safe and Effective in SLE and APS

In Vitro Fertilization is Safe and Effective in SLE and APS

By

Study evaluated the complications and success rates for IVF in women with systemic lupus erythematosus or antiphospholipid syndrome.

Systemic Lupus Erythematosus Increases Incidence of High-Risk HPV

Systemic Lupus Erythematosus Increases Incidence of High-Risk HPV

By

Three-year follow-up shows statistically significant increase in cumulative presence of HPV infection.

Depression in Systemic Lupus Erythematosus Linked to Cardiovascular Disease

Depression in Systemic Lupus Erythematosus Linked to Cardiovascular Disease

By

Women with systemic lupus erythematosus and depression were more likely to have increased carotid intima-media thickness compared with those with SLE without depression.

No Increased Risk of CV Death in Cutaneous Lupus Erythematosus

No Increased Risk of CV Death in Cutaneous Lupus Erythematosus

By

Patients with cutaneous lupus erythematosus (CLE) were assessed for their risk of cerebrovascular accidents, ischemic heart disease, and peripheral arterial disease.

Efficacy of Targeted Interferon-α Inhibition in SLE

Efficacy of Targeted Interferon-α Inhibition in SLE

By

Eligible participants participated in a phase IIb trial of sifalimumab to determine the drug's effect on moderate-to-severe active SLE.

Sign Up for Free e-newsletters